Entries of Garbe, Claus on the publication server

Livingstone, Elisabeth, Zimmer, Lisa, Hassel, Jessica C., Fluck, Michael, Eigentler, Thomas K., Loquai, Carmen, Haferkamp, Sebastian , Gutzmer, Ralf, Meier, Friedegund , Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian , Kiecker, Felix, Dippel, Edgar, Roesch, Alexander, Ziemer, Mirjana, Conrad, Beate, Körner, Silvia, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C., Schadendorf, Dirk, Livingstone, Elisabeth, Zimmer, Lisa, Hassel, Jessica C., Fluck, Michael, Eigentler, Thomas K., Loquai, Carmen, Haferkamp, Sebastian, Gutzmer, Ralf, Meier, Friedegund, Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian, Kiecker, Felix, Dippel, Edgar, Roesch, Alexander, Ziemer, Mirjana, Conrad, Beate, Körner, Silvia, Simon, Jan-Christoph, Herbst, Rudolf A., Berking, Carola, Utikal, Jochen, Sell, Sabine, Martens, Uwe M., Terheyden, Patrick, Stadler, Rudolf, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C. and Schadendorf, Dirk (2022) Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial. The Lancet 400 (10358), pp. 1117-1129. Fulltext not available.

Zimmer, Lisa, Livingstone, Elisabeth, Hassel, Jessica C., Fluck, Michael, Eigentler, Thomas, Loquai, Carmen, Haferkamp, Sebastian, Gutzmer, Ralf, Meier, Friedegund, Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian, Kieker, Felix, Dippel, Edgar, Rösch, Alexander, Simon, Jan-Christoph, Conrad, Beate, Körner, Silvia, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C., Schadendorf, Dirk, Berking, Carola, Herbst, Rudolf A., Martens, Uwe M., Sell, Sabine, Stadler, Rudolf, Terheyden, Patrick and Utikal, Jochen (2020) Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet 395 (10236), pp. 1558-1568. Fulltext not available.

Amaral, Teresa, Kiecker, Felix, Schaefer, Sarah, Stege, Henner, Kaehler, Katharina, Terheyden, Patrick, Gesierich, Anja, Gutzmer, Ralf, Haferkamp, Sebastian, Uttikal, Jochen, Berking, Carola, Rafei-Shamsabadi, David, Reinhardt, Lydia, Meier, Friedegund, Karoglan, Ante, Posch, Christian, Gambichler, Thilo, Pfoehler, Claudia, Thoms, Kai, Tietze, Julia, Debus, Dirk, Herbst, Rudolf, Emmert, Steffen, Loquai, Carmen, Hassel, Jessica C, Meiss, Frank, Tueting, Thomas, Heinrich, Vanessa, Eigentler, Thomas, Garbe, Claus and Zimmer, Lisa (2020) Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients. Journal for ImmunoTherapy of Cancer 8 (1), e000333. Fulltext not available.

Leiter, Ulrike, Loquai, Carmen, Reinhardt, Lydia, Rafei-Shamsabadi, David , Gutzmer, Ralf, Kaehler, Katharina, Heinzerling, Lucie, Hassel, Jessica C, Glutsch, Valerie, Sirokay, Judith, Schlecht, Nora, Rübben, Albert, Gambichler, Thilo, Schatton, Kerstin, Pfoehler, Claudia, Franklin, Cindy, Terheyden, Patrick, Haferkamp, Sebastian, Mohr, Peter, Bischof, Lena, Livingstone, Elisabeth, Zimmer, Lisa, Weichenthal, Michael, Schadendorf, Dirk, Meiwes, Andreas, Keim, Ulrike, Garbe, Claus, Becker, Jürgen Christian and Ugurel, Selma (2020) Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients. Journal for ImmunoTherapy of Cancer 8 (2), e000897. Fulltext not available.

Leiter, Ulrike, Heppt, Markus V., Steeb, Theresa, Amaral, Teresa, Bauer, Andrea, Becker, Jürgen C., Breitbart, Eckhardt, Breuninger, Helmut, Diepgen, Thomas, Dirschka, Thomas, Eigentler, Thomas, Flaig, Michael, Follmann, Markus, Fritz, Klaus, Greinert, Rüdiger, Gutzmer, Ralf, Hillen, Uwe, Ihrler, Stephan, John, Swen Malte, Kölbl, Oliver, Kraywinkel, Klaus, Löser, Christoph, Nashan, Dorothee, Noor, Seema, Nothacker, Monika, Pfannenberg, Christina, Salavastru, Carmen, Schmitz, Lutz, Stockfleth, Eggert, Szeimies, Rolf‐Markus, Ulrich, Claas, Welzel, Julia, Wermker, Kai, Garbe, Claus and Berking, Carola (2020) S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18 (4), pp. 400-413. Fulltext not available.

Heppt, Markus V., Leiter, Ulrike, Steeb, Theresa, Amaral, Teresa, Bauer, Andrea, Becker, Jürgen C., Breitbart, Eckhard, Breuninger, Helmut, Diepgen, Thomas, Dirschka, Thomas, Eigentler, Thomas, Flaig, Michael, Follmann, Markus, Fritz, Klaus, Greinert, Rüdiger, Gutzmer, Ralf, Hillen, Uwe, Ihrler, Stephan, John, Swen Malte, Kölbl, Oliver, Kraywinkel, Klaus, Löser, Christoph, Nashan, Dorothée, Noor, Seema, Nothacker, Monika, Pfannenberg, Christina, Salavastru, Carmen, Schmitz, Lutz, Stockfleth, Eggert, Szeimies, Rolf‐Markus, Ulrich, Claas, Welzel, Julia, Wermker, Kai, Berking, Carola and Garbe, Claus (2020) S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18 (3), pp. 275-294. Fulltext not available.

Leiter, Ulrike, Heppt, Markus V., Steeb, Theresa, Amaral, Teresa, Bauer, Andrea, Becker, Jürgen C., Breitbart, Eckhardt, Breuninger, Helmut, Diepgen, Thomas, Dirschka, Thomas, Eigentler, Thomas, Flaig, Michael, Follmann, Markus, Fritz, Klaus, Greinert, Rüdiger, Gutzmer, Ralf, Hillen, Uwe, Ihrler, Stephan, John, Swen Malte, Kölbl, Oliver, Kraywinkel, Klaus, Löser, Christoph, Nashan, Dorothee, Noor, Seema, Nothacker, Monika, Pfannenberg, Christina, Salavastru, Carmen, Schmitz, Lutz, Stockfleth, Eggert, Szeimies, Rolf‐Markus, Ulrich, Claas, Welzel, Julia, Wermker, Kai, Garbe, Claus and Berking, Carola (2020) S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Prävention und Berufskrankheit. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18 (4), pp. 400-413. Fulltext not available.

Kreft, Sophia, Gesierich, Anja, Eigentler, Thomas, Franklin, Cindy, Valpione, Sara, Ugurel, Selma, Utikal, Jochen, Haferkamp, Sebastian, Blank, Christian, Larkin, James , Garbe, Claus , Schadendorf, Dirk, Lorigan, Paul and Schilling, Bastian (2019) Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma. European Journal of Cancer 116, pp. 207-215. Fulltext not available.

Ulmer, Anja, Dietz, Klaus , Werner-Klein, Melanie, Häfner, Hans-Martin, Schulz, Claudia, Renner, Philipp, Weber, Florian, Breuninger, Helmut, Röcken, Martin, Garbe, Claus , Fierlbeck, Gerhard and Klein, Christoph A. (2018) The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival. European Journal of Cancer 91, pp. 1-10. Fulltext not available.

Offenmueller, Sonja, Leiter, Ulrike , Bernbeck, Benedikt, Garbe, Claus, Eigentler, Thomas, Borkhardt, Arndt, Classen, Carl Friedrich, Corbacioglu, Selim, Dirksen, Uta, Ebetsberger-Dachs, Georg, Heinzerling, Lucie, Jorch, Norbert, Kuhlen, Michaela, Lawlor, Jennifer, Niggli, Felix, Streiter, Monika, Schneider, Dominik T. and Brecht, Ines (2017) Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP). Klinische Pädiatrie 229 (06), pp. 322-328. Fulltext not available.

Kamenisch, York, Baban, Tarza S.A., Schuller, Winfried, von Thaler, Anna-Katharina, Sinnberg, Tobias, Metzler, Gisela, Bauer, Jürgen, Schittek, Birgit, Garbe, Claus, Rocken, Martin and Berneburg, Mark (2016) UVA-Irradiation Induces Melanoma Invasion via the Enhanced Warburg Effect. Journal of Investigative Dermatology 136 (9), pp. 1866-1875. Fulltext not available.

Eigentler, Thomas , Assi, Zeinab, Hassel, Jessica C., Heinzerling, Lucie, Starz, Hans, Berneburg, Mark, Bauer, Jürgen and Garbe, Claus (2016) Which melanoma patient carries a BRAF-mutation? A comparison of predictive models. Oncotarget 7 (24). Fulltext not available.

Ulmer, Anja, Dietz, Klaus, Hodak, Isabelle, Polzer, Bernhard, Scheitler, Sebastian, Yildiz, Murat, Czyz, Zbigniew, Lehnert, Petra, Fehm, Tanja, Hafner, Christian, Schanz, Stefan, Röcken, Martin, Garbe, Claus, Breuning, Helmut, Fierlbeck, Gerhard and Klein, Christoph A. (2014) Quantitative Measurement of Melanoma Spread in Sentinel Lymph Nodes and Survival. PLoS ONE 11 (2), e001604.

Eigentler, Thomas K., Figl, Adina, Krex, Dietmar, Mohr, Peter, Mauch, Cornelia, Rass, Knut, Bostroem, Azize, Heese, Oliver, Koelbl, Oliver, Garbe, Claus and Schadendorf, Dirk (2011) Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 117 (8), pp. 1697-1703. Fulltext not available.